Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review
Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone of antiplatelet therapy and is used in secondary prevention of cardiovascular disease. Disagreement over the optimal maintenance dosage still exists; in America and Europe the most used doses of...
Saved in:
Main Authors: | Carol Gravinese (Author), Matteo Bianco (Author), Enrico Cerrato (Author), Paola Destefanis (Author), Alessia Luciano (Author), Alessandro Bernardi (Author), Simone Bellucca (Author), Ferdinando Varbella (Author), Fiorenzo Gaita (Author), Roberto Pozzi (Author) |
---|---|
Format: | Book |
Published: |
Baqiyatallah University of Medical Sciences,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
by: Baorui Wang, et al.
Published: (2023) -
Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
by: Hemlata, et al.
Published: (2013) -
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
by: Pi L, et al.
Published: (2018) -
Cornerstones in Contemporary Inorganic Chemistry
Published: (2022) -
Britain's Imperial Cornerstone in China
by: Brunero, Donna
Published: (2006)